PIVKA-II: A biomarker for diagnosing and monitoring patients with pancreatic adenocarcinoma

Abstract

These data are the first showing a decreased PIVKA-II serum levels after surgery in PDAC patients and reporting PIVKA-II expression in PDAC tissue. Further studies are needed to confirm these findings and to determine PIVKA-II usefulness in diagnosing and monitoring PDAC patients.